Glaxosmithkline Pty Ltd
⚠️ Moderate Risk
FEI: 3004172487 • Boronia • AUSTRALIA
FEI Number
3004172487
Location
Boronia
Country
AUSTRALIAAddress
1061 Mountian, , Boronia, , Australia
Moderate Risk
FDA Import Risk Assessment
This firm has a moderate history of FDA import refusals. Some attention may be warranted.
Statistics
Score Breakdown
How is this score calculated?
Proprietary Algorithm
- 40% Violation Severity — AI-assessed (1-10)
- 30% Refusal Volume — Logarithmic scale
- 20% Recency — Decays over 5 years
- 10% Frequency — Refusals per year
© ImportRefusal.com Original Analysis
Violation Summary
Refusal History
| Date | Product | Violations | Division |
|---|---|---|---|
| 11/19/2003 | 61TNY99ANTI-EMETIC/NAUSEANT N.E.C. | 342PERSONALRX | Seattle District Office (SEA-DO) |
Frequently Asked Questions
What is Glaxosmithkline Pty Ltd's FDA import refusal history?
Glaxosmithkline Pty Ltd (FEI: 3004172487) has 1 FDA import refusal record(s) in our database, spanning from 11/19/2003 to 11/19/2003.
What is an FEI number?
FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. Glaxosmithkline Pty Ltd's FEI number is 3004172487.
What types of violations has Glaxosmithkline Pty Ltd received?
Glaxosmithkline Pty Ltd has been cited for 1 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.
Where does this information about Glaxosmithkline Pty Ltd come from?
All FDA import refusal data for Glaxosmithkline Pty Ltd is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.
Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.